MPG.eBooks - Search Results - "Insurance, Health, Reimbursement"

1

CADTH Canadian Drug Expert Committee recommendation: Tapentadol hydrochloride (Nucynta extended-release -- Paladin Labs Inc.) : indication : management of pain severe enough to req...

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Insurance, Health, Reimbursement...”

Read Now

2

CADTH Canadian drug expert committee recommendation: Upadacitinib (Rinvoq -- abbVie) : indication : for the treatment of adults with moderately to severely active rheumatoid arthri...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Insurance, Health, Reimbursement...”

Read Now

3

CADTH Canadian drug expert committee recommendation: Cyclosporine 0.1% (Verkazia -- Santen Canada Inc.) : indication : treatment of severe vernal keratoconjunctivitis in children f...

Published 2019

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Insurance, Health, Reimbursement...”

Read Now

4

CADTH Canadian drug expert committee recommendation: Inotersen (Tegsedi -- Akcea Therapeutics, Inc.) : indication : treatment of polyneuropathy in adults with hereditary transthyre...

Published 2019

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Insurance, Health, Reimbursement...”

Read Now

5

CADTH Canadian Drug Expert Committee recommendation: Ulipristal acetate (Fibristal -- Allergan Inc.) : indication: uterine fibroids

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Insurance, Health, Reimbursement...”

Read Now

6

Ensuring access to medicines : how to redesign pricing, reimbursement and procurement?

by Vogler, Sabine, Paris, Valérie, Panteli, Dimitra
Published 2018

World Health Organization, Regional Office for Europe

Subjects: “...Insurance, Health, Reimbursement...”

Read Now

7

CADTH Canadian Drug Expert Committee recommendation: Ulipristal acetate (Fibristal -- Allergan Inc.) : indication: uterine fibroids

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Insurance, Health, Reimbursement...”

Read Now

8

CADTH Canadian drug expert committee recommendation: Vortioxetine (Trintellix --Lundbeck Canada Inc.) : indication: for the treatment of major depressive disorder in adults

Published 2020

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Insurance, Health, Reimbursement...”

Read Now

9

CADTH Canadian Drug Expert Committee recommendation: Baricitinib (Olumiant -- Eli Lilly Canada Inc.) : indication : for use in combination with methotrexate (MTX) for the treatment...

Published 2019

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Insurance, Health, Reimbursement...”

Read Now

10

CADTH Canadian Drug Expert Committee recommendation: Brolucizumab (Beovu -- Novartis Pharmaceuticals Canada Inc.) : indication : treatment of neovascular (wet) age-related macular...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Insurance, Health, Reimbursement...”

Read Now

11

CADTH Canadian Drug Expert Committee recommendation: Sodium zirconium cyclosilicate (Lokelma -- Astrazeneca Canada Inc.) : indication: hyperkalemia

Published 2020

CADTH

Subjects: “...Insurance, Health, Reimbursement...”

Read Now

12

CADTH Canadian Drug Expert Committee recommendation: Obeticholic acid (Ocaliva--Intercept Pharmaceuticals Canada) : indication : primary biliary cholangitis

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Insurance, Health, Reimbursement...”

Read Now

13

CADTH Canadian drug expert committee recommendation: Lanadelumab (Takhzyro -- shire pharma Canada ULC) : indication: for the routine prevention of attacks of hereditary angioedema...

Published 2019

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Insurance, Health, Reimbursement...”

Read Now

14

CADTH Canadian Drug Expert Committee recommendation: Vedolizumab (Entyvio -- Takeda Canada Inc.) : indication : for the treatment of adult patients with moderately to severely acti...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Insurance, Health, Reimbursement...”

Read Now

15

CADTH Canadian Drug Expert Committee recommendation: Iron isomaltoside 1000 (Monoferric -- pharmacosmos A/S) : indication: for the treatment of iron deficiency anemia in adult pati...

Published 2020

CADTH

Subjects: “...Insurance, Health, Reimbursement...”

Read Now

16

CADTH Canadian Drug Expert Committee recommendation: Fluticasone Propionate (Aermony respiclick -- Teva Canada Innovation) : indication : maintenance treatment of asthma in patient...

Published 2018

CADTH

Subjects: “...Insurance, Health, Reimbursement...”

Read Now

17

CADTH Canadian Drug Expert Committee recommendation: Fluticasone Propionate (Aermony respiclick -- Teva Canada Innovation) : indication : maintenance treatment of asthma in patient...

Published 2018

CADTH

Subjects: “...Insurance, Health, Reimbursement...”

Read Now

18

CADTH Canadian drug expert committee recommendation: Burosumab (Crysvita -- Kyowa Kirin Limited) : indication : treatment of x-linked hypophosphatemia

Published 2020

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Insurance, Health, Reimbursement...”

Read Now

19

CADTH Canadian Drug Expert Committee final recommendation: Mifepristone and misoprostol (Mifegymiso -- Celopharma Inc.) : indication: medical termination of pregnancy

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Insurance, Health, Reimbursement...”

Read Now

20

CADTH Canadian Drug Expert Committee recommendation: Nusinersen (Spinraza -- Biogen Canada Inc.) : indication : treatment of 5q spinal muscular atrophy

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Insurance, Health, Reimbursement...”

Narrow Search